TABLE OF CONTENT GRAPHIC

Introduction
The histone deacetylase inhibitors (HDACis) are chemically-heterogeneous promising anticancer agents which restore a relaxed, hyperacetylated chromatin structure and potentially lead to re-expression of silenced genes and/or silencing of downstream genes, ultimately inducing death, apoptosis, and cell cycle arrest in cancer cells also via non histone-targeted mechanisms such as perturbations of p53, cytokine signaling pathways and angiogenesis (e.g. 1 ).
HDACis are grouped into different categories on the basis of their chemical nature, and the consequence of this molecular diversity is that the precise mechanism through which these compounds work is still poorly understood.
Suberoylanilide hydroxamic acid (SAHA), a.k.a. Vorinostat, is a prototypical HDACi targeting class I and II HDAC approved in 2006 by the Food and Drug Administration for treatment of cutaneous T-cell lymphoma. 2 A number of studies have focussed on the understanding of the biological properties of the compound as an anticancer agent, especially against tumors with intrinsic highly-malignant potential. Triple-negative breast cancer (TNBC) is a tumor histotype, which is poorly responsive to hormonal therapies and to HER2-targeting drugs and usually associated with worse prognosis than other breast cancers. It is therefore very important to develop and test novel drugs or analogues of pre-existing drugs that counteract TNBC cell growth. In this context, drugs targeting multiple signaling pathways and epigenetic drugs appear to be the most promising. 3 Exposure of TNBC MDA-MB231 cells to SAHA was found to determine the modification of selected gene expression patterns, the disruption of transduction signalling, and the onset of apoptosis. [4] [5] [6] [7] Several manipulations of the core structure of SAHA have been carried out to probe the effect of such SAR (structure activity relationships) modifications on both HDAC inhibitory activity and cytotoxic effects on cancer cells (e.g. 8 ) . HDACis typically contain a cap (often aryl group), a linker and a zinc-binding group. Spencer et al. 9 reported the synthesis of metal-based SAHA analogues that contain a ferrocene cap that are air stable and readily modifiable synthetically, such as Jay Amin Hydroxamic Acid (JAHA). If compared with parental SAHA, JAHA displays similar broad inhibitory profiles towards class I HDACs, including HDAC8, whereas it is inactive on class IIa HDACs. Indeed, many studies have shown that the introduction of a ferrocene motif can lead to significant changes in bioactivity not only due to its size and shape, which may alter interactions with crucial residues in active sites for example, but also due to its potential for redox activity (Fe(II)/Fe(III) and induction of reactive oxygen species.
leaving pAKT levels unaltered in MDA-MB231 cells. The resulting inhibition of DNMT1 and DNMT3b methyltransferase activity resulted in a generalized DNA demethylation following JAHA treatment with consequent implications in transcriptional regulation and gene expression pattern.
These cumulative results highlighted a modification of the biological effect consequent to the manipulation of the original molecular structure. It is widely-acknowledged that the characterization of the biological activity of new potential anti-cancer compounds, such as ferrocene-based SAHA analogues, is necessary to establish drug safety and efficacy profiles. In addition, information on the mode of action of the different HDACis may reveal new molecular targets of putative applicative interest, which ultimately may be useful in the design of more appropriate intervention and therapies for tumours with inherent aggressive biology and limited treatment options, such as TNBCs. In order to get novel insight on how MDA-MB231 breast cancer cells respond to the cytotoxic effect induced by JAHA, and to compare the biological effect of the related compounds JAHA and SAHA, we have employed a combination of differential display-PCR, proteome analysis and Comet assay techniques and shown different molecular signature profiles induced by exposition to either HDACis. As well as expanding the biological knowledge of the effect exerted by the modifications in compound structures on cell phenotype, the molecular elements put in evidence in our study may provide promising targets for therapeutic interventions on TNBCs.
Experimental procedures
Cells and treatments
MDA-MB231 breast tumor cells were maintained in RPMI 1640 medium plus 10% fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2.5 mg/L amphotericin B (Invitrogen, Carlsbad, CA/USA), at 37 °C in a 5% CO2 atmosphere. The cells were detached from flasks with 0.05% trypsin-EDTA, counted, and plated at the necessary density for treatment after achieving 60−80% confluency. The HDACis SAHA and JAHA, the latter synthesized as reported in Spencer at al. 9 , were dissolved in dimethyl sulfoxide as stock solutions. One x 10 6 cells were plated in 75 cm 2 flasks, and allowed to adhere overnight. Then, the cells were treated with either JAHA or SAHA at 8,45 μM concentration, or with the vehicle for 18, 24, and 48 hours.
Messenger RNA isolation and reverse transcription
Isolation of total RNA from monolayers of trypsinized control and HDACi-exposed cells and reverse transcriptase reaction were performed with TRIzol reagent (Invitrogen) as described by Sirchia and Luparello. 17 Messenger RNA-enriched samples from total RNA preparations were obtained using Terminator™ 5′-Phosphate-Dependent Exonuclease (Epicentre, Madison, WI/USA) following manufacturer's instructions and the mRNA preparations were purified from excess EDTA, tRNA, 5S rRNA, and other small RNA species, by LiCl precipitation. The cDNAs were synthesized from 250 ng of mRNA in the presence of random hexamer primers, using Superscript II reverse transcriptase (Invitrogen), and their quality was checked by amplification of "housekeeping" -actin cDNA. The peptide and fragment ion mass tolerances used were 20 ppm and 0.6 Da respectively.
Differential display (DD) and real time-PCR
Peptides with Mascot score exceeding the threshold value corresponding to <5 % false positive rate calculated by Mascot procedure, were considered to be positively identified. At least two peptides for each protein with a score above the threshold were required for the identification.
The qualitative analysis of protein/peptide lists generated by the Mascot search engine was performed using MScan, whereas for quantitative estimation the MSparky software tool was used. The statistical analysis was performed using the DiffProt software, thereby obtaining a list of differentially-expressed proteins. For each of them the R (ratio) and F (fold change) values were estimated to identify up/down-regulation and fold changing, respectively. Data are shown as mean ± s.e.m. of independent triplicate experiments. The p values obtained were corrected for multiple-hypothesis testing using a two-step Benjamini-Hochberg procedure that controlled for the false discovery rate. 23 The relative protein abundances with adjusted p values ≤ 0.05 and fold-change (FC) values ≥ 1.5 were considered as significant in at least one of the studied groups. For graphical summaries and to evaluate the relationships among the studied samples, we used principal component analysis and Ward's linkage hierarchical clustering. All statistical analyses were performed with MStat software. The software used for bioinformatics analyses were available at http://proteom.ibb.waw.pl/index.en.html.
Comet assay
The DNA damage was estimated on the basis of tail length (TL), tail moment (TM), olive tail moment (OTM) and % tail DNA (% DNA). Statistical analysis of the data was performed using
Excel software.
Results
To search for differentially-expressed genes in MDA-MB231 cells exposed to 8.45 μM
HDACis for 18, 24 and 48 h, DD-PCR was performed on enriched mRNA samples isolated from control and treated cell preparations, in the presence of combinations of the arbitrary primers, as listed previously. After PAGE and silver stain, a number of bands appeared differently-displayed in parallel control and treated samples, and they were cut from the gel and submitted to further analysis. To this purpose, the cDNA contained in the bands was purified, re-amplified until purity and adequate yield, and then the material was submitted to sequencing. In order to expand the search of JAHA-associated signatures at the protein level, proteomic analyses were performed and showed a differential expression of eleven proteins (six, one and four associated to 18, 24 and 48 h of treatment with JAHA at 8.45 μM, respectively). As shown in Table 2 , of the six proteins associated to 18 h-treatment, four were down-regulated (i.e. is up-regulated in several human cancers, including TNBC, where it was found to be involved in epithelial-mesenchymal transition, anoikis resistance and metastatic spread. 26, 27 In addition, a number of studies performed on nerve and choriocarcinoma cell models have demonstrated its powerful role in repair of oxidative DNA damage and related inhibition of apoptosis. In particular, in rat cortical neurons the NTRK-2 protective activity was found to be accomplished via PI3K, pAKT, pCREB and the expression of APE1 (apurinic/apyrimidinic endonuclease-1), a key component of the base excision DNA repair pathway. 28, 29 RAD-50 is known to participate with MRE11 and NBS1 to the formation of the MRN complex, which coordinates the repair of DNA double strand breaks in the nucleus. 30 The inability of SAHA to trigger RAD50 upregulation was demonstrated also in prostate cancer cells by Lee et al., 31 thereby further confirming that this is a JAHA-selective gene signature. Evidence of JAHA's role as antioxidative stress compound emerged also from proteomic analyses demonstrating the specific accumulation of glutaredoxin-1, cystatin-B, and, more prominently and at a later time, sulfiredoxin-1. The latter one is an ATP-dependent cytoprotective antioxidant enzyme known to catalyze peroxiredoxin reactivation and deglutathionylation of glutathionylated proteins in several cytotypes exposed to diversified chemical and biological stimuli that elicit the production of reactive oxygen species. 32 Glutaredoxin-1 catalyzes the reversible reduction of glutathioneprotein mixed disulfides and is implicated in DNA repair and mitochondrial DNA synthesis, thereby highly contributing to the antioxidant cellular defense system. 33 Cystatin-B is an inhibitor of lysosomal cysteine cathepsin that has been proven to protect mouse mammary tumour cells from oxidative stress and consequent death. 34 The ability of JAHA to reverse DNA damage in cultured cells, at least in part, was demonstrated by a Comet assay in JAHA/VP16 cotreatment experiments thereby further substantiating that there is a correlation between the increase of the molecular signatures involved in DNA repair mechanisms and the peculiar ability of JAHA to reduce DNA damage, through a molecular mechanism which is still to be determined. Noteworthy, this finding is contrary to what has been described as a general aspect of HDACis, 35 i.e. the inhibition of different aspects of DNA repair including the interference with coordination of ataxia-telangiectasia and Rad3-related (ATR) activation and signalling which is downstream Rad50 phosphorylation; 36 this peculiar property of JAHA seems truly interesting since it is uncommon but beneficial to find a HDACi that simultaneously increases DNA repair. Other specific JAHA signatures are represented by the early down-regulation of the high mobility group proteins and the up-regulation of RRBP1 that continues also in later time coupled with the late up-regulation of prelamin A/C. The first ones are architectural transcription factors, and a miRNA-triggered decrease of the amount of high mobility group protein-B1 has been proven to impair MDA-MB231 cell cycle progression and render these and other mammalian cytotypes sensitive to a number of diversified death stimuli. 37, 38 Noteworthy, high mobility group proteins-B1 and -B2 are known to play a DNA damage-sensing role and induce phosphorylation of p53 as a response; 39 therefore, the decrease of the intracellular amount of these chromatin-associated factors may be responsible, at least in part, of the previouslyobserved lack of apoptosis induction after cell exposure to JAHA. 25 On the other hand, apoptosis restraining could also result from constant RRBP1 accumulation; this ribosome-binding factor is associated to unfolded protein response in the endoplasmic reticulum and its up-regulation has been found to render lung cancer cells more resistant to the stress and to alleviate apoptosis. 40 Accumulation of prelamin A-C is indicative of impairment of protein farnesylation which is a pre-requisite for its processing. 41 It is known that farnesylated species are cytotoxic, and in particular the accumulation of prelamin A in fibroblasts by siRNA transfection has been shown to increase the levels of reactive oxygen species, affect mitochondrial respiration and alter the expression of the genes encoding detoxifying enzymes. 42 In addition, it is worth mentioning that farnesylation represents a maturation step for Ras GTPase 43 representing a marker of a low proliferative activity. 46 On the other hand, HN1, which is an interaction partner of the inactive GSK3β/β-catenin/APC complex contributing to ubiquitindependent proteasomal degradation of β-catenin, when over-expressed in prostate cancer cells have been shown to trigger their accumulation at G2/M checkpoint, and to reduce the proliferation rate. 47 These literature data are consistent with our previous results 25 demonstrating cell cycle perturbation and a delay in G2/M transition in MDA-MB231 cells exposed to JAHA.
Various are the intracellular roles played by the giant AHNAK protein in very diverse biological processes. 48 In breast cancer, this protein was found to be localized in lipid rafts thus suggesting its involvement in signaling pathways also linked with the reorganization of actin submembraneous network. 49 In particular, when AHNAK was over-expressed in TNBC cell lines, such as MDA-MB231, a marked inhibition of ERK phosphorylation was observed; therefore, it is conceivable that JAHA-mediated AHNAK down-regulation in this cell line may be at least in part responsible of the observed early reduction of the amount of pERK in MDA-MB231 wells exposed to JAHA, as reported by Librizzi et al. 16 A number of gene and, more prominently, protein signatures, involved in different biological events, have been found associated only to SAHA-, and not JAHA-, treatment under the same experimental conditions. Thus, as opposed to SAHA, JAHA did not appear to be active on the control of specific enzyme activities via i) the down-regulation of the expression of BIG-3
encoding for an A-kinase anchoring protein, 50 and of PKC whose depletion have been proven to restrain TNBC growth and address cells to senescence, 51, 52 ii) the increase of accumulation of eukaryotic translation initiation factor 4H, an activator of the RNA helicase eIF4A, 53 and iii) the decrease of the amount of nicotinamide phosphoribosyltransferase, whose inhibition was found to suppress breast tumour growth in vivo in a xenograft model. 54 Other biological mediators whose expression/accumulation was affected by SAHA, but not JAHA, are i) the proliferation- In summary, in this study we have established a number of molecular signatures in response to the HDACi JAHA in a TNBC cell model, and although this compound is closely-related to the parental molecule SAHA, we have revealed some substantial differences in the biomarkers of drug responses. In contrast to the more numerous and diversified changes induced by SAHA, JAHA displays a more selective impact on the expression of molecular signatures by increasing the expression of some molecular signatures involved in anti-oxidant activity and DNA repair.
This specific property will represent a challenge which has to be taken into account in a future consideration of this molecule as an anticancer drug. Literature data had already reported the effect of SAHA or other HDACis on only five among the molecular signatures identified in this study, i.e. 78 kDa glucose-regulated protein, integrin 1, NHE-RF1, reticulocalbin-1 and histone H1.0. [68] [69] [70] [71] [72] Therefore, our work also contributes to expand the list of molecular signature responsive to cell exposure to these enzyme inhibitors. On the basis of the present exploratory study, further work using global gene expression and proteomic profiling protocols will allow a further understanding of the selective molecular response associated to their mechanisms of action, and to define key client transcripts and proteins for either specific compound with potential clinical significance minimizing the problematic effects and emphasizing the therapeutic ones. 
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